Registry of Toxic Effects of Chemical Substances (RTECS)
ShareCompartir
Nitroglycerin
RTECS #
QX2100000CAS #
55-63-0Updated
December 2013Molecular Weight
227.11Molecular Formula
C3H5N3O9Synonyms
1,2,3-Propanetriol, trinitrate (9CI)1,2,3-Propanetriyl nitrate
Angibid
Anginine
Angiolingual
Angorin
Blasting gelatin
Blasting oil
Cardamist
Gilucor nitro
Glonoin
Glycerintrinitrate (Czech)
Glycerol trinitrate
Glycerol(trinitrate de) (French)
Glycerol, nitric acid triester
Glyceroltrinitraat (Dutch)
Glyceryl nitrate
Glyceryl trinitrate
GTN
Klavikordal
Lenitral
Myocon
Myoglycerin
NG
Niglin
Niglycon
Niong
Nitora
Nitric acid triester of glycerol
Nitrin
Nitrine
Nitrine-TDC
Nitro-dur
Nitroglicerina (Italian)
Nitrogliceryna (Polish)
Nitroglycerin (ACGIH:OSHA)
Nitroglycerin, spirits of
Nitroglycerin-ACC
Nitroglycerine
Nitroglycerol
Nitroglyn
Nitrolan
Nitro-lent
Nitroletten
Nitrolingual
Nitrolowe
Nitromel
Nitronet
Nitrong
Nitrorectal
Nitro-span
Nitrostabilin
Nitrostat
Nitrozell retard
NK-843
NTG
Nysconitrine
Perglottal
Propanetriol trinitrate
RCRA waste number P081
S.N.G
SK-106N
Solution glyceryl trinitrate
Soup
Spirit of glonoin
Spirit of glyceryl trinitrate
Spirit of trinitroglycerin
Temponitrin
TNG
Trinalgon
Trinitrin
Trinitroglycerin
Trinitroglycerol
Trinitrol
Vasoglyn
Skin and Eye Irritation and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| eye /rabbit | 0.1 mL | HPV319 -,-,2002 | |
| skin /rabbit | 500 mg/24H | mild | NTIS** AD-B011-150 |
| skin /rabbit | 0.5 mL | mild | HPV319 -,-,2002 |
Mutation Data and Reference
| System Test | Route/Organism/Tissue | Dose | Reference |
|---|---|---|---|
| DNA inhibition | mammary gland/cattle | 30 µmol/L/24H | MOCAE8 59,1044,2001 |
| mutation in mammalian somatic cells | other cell types/human | 800 µmol/L/24H | EMMUEG 38,261,2001 |
| mutation in mammalian somatic cells | intraperitoneal/mouse | 5 mg/kg | JJIND8 92,1429,2000 |
| mutation in microorganisms | /Salmonella typhimurium | 2500 nmol/plate (+enzymatic activation step) | MUREAV 298,187,1993 |
| mutation in microorganisms | /Salmonella typhimurium | 50 µg/well (-enzymatic activation step) | CBINA8 19,77,1977 |
| mutation in microorganisms | /Salmonella typhimurium | 1000 µg/plate (-enzymatic activation step) | HPV319 -,-,2002 |
| mutation in microorganisms | /Salmonella typhimurium | 1000 µg/plate (+enzymatic activation step) | HPV319 -,-,2002 |
| specific locus test | other cell types/human | 800 µmol/L/24H | EMMUEG 38,261,2001 |
| specific locus test | intraperitoneal/mouse | 5 mg/kg | JJIND8 92,1429,2000 |
Reproductive Effects Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| intraperitoneal/rat | 11 mg/kg (7-17D pregnant) | Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Effects on embryo or fetus: Fetal death | YACHDS 13,3807,1985 |
| intraperitoneal/rat | 220 mg/kg (7-17D pregnant) | Reproductive: Effects on embryo or fetus: Extra embryonic structures (e.g., placenta, umbilical cord) Reproductive: Specific developmental abnormalities: Musculoskeletal system | YACHDS 13,3807,1985 |
| intraperitoneal/rat | 2580 mg/kg (91D male/2W pre-7D pregnant) | Reproductive: Maternal effects: Menstrual cycle changes or disorders Reproductive: Effects on fertility: Pre- implantation mortality (e.g., reduction in number of implants per female; total number of implants per corpora lutea) Reproductive: Other effects to embryo or fetus | YACHDS 13,3783,1985 |
| intraperitoneal/rat | 520 mg/kg (17D preg-20D after birth) | Reproductive: Effects on newborn: Growth statistics (e.g., reduced weight gain) | YACHDS 13,3843,1985 |
| oral/rat | 73440 mg/kg (multigeneration) | Reproductive: Other effects on male Reproductive: Other effects on female Reproductive: Effects on fertility: Litter size (e.g., # fetuses per litter; measured before birth) | HPV319 -,-,2002 |
| skin/rat | 3640 mg/kg (17-21D preg/21D after birth) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Effects on newborn: Viability index (e.g., # alive at day 4 per # born alive) | KSRNAM 18,3564,1984 |
Tumorigenic Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| oral/rat | lowest published toxic dose: 36500 mg/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors | ATSUDG 4,88,1980 |
| oral/rat | toxic dose: 438 gm/kg/2Y- continuous | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors Reproductive: Tumorigenic effects: Testicular tumors | ATSUDG 4,88,1980 |
| oral/rat | lowest published toxic dose: 161330 mg/kg/2Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains | HPV319 -,-,2002 |
| oral/rat | lowest published toxic dose: 240170 mg/kg/2Y- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Liver: Tumors Tumorigenic: Increased incidence of tumors in susceptible strains | HPV319 -,-,2002 |
Acute Toxicity Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| intraarterial/Dog | lowest published toxic dose: 1000 ng/kg | Vascular: Measurement of regional blood flow Blood: Changes in spleen | CEXPB9 33,81,2006 |
| intraperitoneal/mouse | lethal dose (50 percent kill): 104 mg/kg | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea Nutritional and Gross Metabolic: Body temperature decrease | IYKEDH 13,90,1982 |
| intraperitoneal/rabbit | lethal dose (50 percent kill): 189 mg/kg | NIIRDN -,786,1990 | |
| intraperitoneal/rat | lethal dose (50 percent kill): 102 mg/kg | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea Nutritional and Gross Metabolic: Body temperature decrease | IYKEDH 13,90,1982 |
| intraperitoneal/rat | lowest published toxic dose: 10 mg/kg | Behavioral: Analgesia | EJPHAZ 464,159,2003 |
| intravenous/cat | lowest published toxic dose: 0.5 mg/kg | Cardiac: Change in force of contraction Cardiac: Pulse rate increased without fall in BP Vascular: BP lowering not characterized in autonomic section | FATOAO 44,174,1981 |
| intravenous/cat | lowest published toxic dose: 1 mg/kg | Cardiac: Other changes Vascular: BP lowering not characterized in autonomic section Vascular: Measurement of regional blood flow | FATOAO 47,55,1984 |
| intravenous/cat | lowest published lethal dose: 5 mg/kg | Cardiac: Change in conduction velocity Vascular: BP lowering not characterized in autonomic section | FATOAO 47,55,1984 |
| intravenous/Dog | lethal dose (50 percent kill): 19 mg/kg | Eye: Hemorrhage Behavioral: Convulsions or effect on seizure threshold Lung, Thorax, or Respiration: Dyspnea | OYYAA2 22,629,1981 |
| intravenous/man | lowest published toxic dose: 51429 µg/kg/2D- intermittent | Brain and Coverings: Encephalitis Eye: Miosis (pupilliary constriction) Eye: Corneal damage | AIMEAS 101,500,1984 |
| intravenous/man | lowest published toxic dose: 7.14 ng/kg | Vascular: Regional or general arteriolar or venous dilation | CLPTAT 67,22,2000 |
| intravenous/mouse | lethal dose (50 percent kill): 30 mg/kg | FATOAO 47,55,1984 | |
| intravenous/mouse | lethal dose (50 percent kill): 10600 µg/kg | Behavioral: Ataxia Lung, Thorax, or Respiration: Dyspnea Nutritional and Gross Metabolic: Body temperature decrease | IYKEDH 13,90,1982 |
| intravenous/rabbit | lethal dose (50 percent kill): 45 mg/kg | NIIRDN 6,547,1982 | |
| intravenous/rabbit | lowest published toxic dose: 340 µg/kg | Cardiac: Change in rate Vascular: BP lowering not characterized in autonomic section | CEXPB9 30,812,2003 |
| intravenous/rabbit | lethal dose (50 percent kill): 45 mg/kg | Behavioral: Convulsions or effect on seizure threshold Cardiac: Change in rate Gastrointestinal: Changes in structure or function of salivary glands | HPV319 -,-,2002 |
| intravenous/rat | lowest published toxic dose: 8 µg/kg | Vascular: BP lowering not characterized in autonomic section | BIPBU* 24,1370,2001 |
| intravenous/rat | lowest published toxic dose: 60 µg/kg | Brain and Coverings: Other degenerative changes Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | JOETD7 136,267,2011 |
| intravenous/rat | lowest published toxic dose: 1714.3 µg/kg/1H | Behavioral: Tolerance | AAPSP* 4,10,2002 |
| intravenous/rat | lethal dose (50 percent kill): 23200 µg/kg | Behavioral: Somnolence (general depressed activity) Behavioral: Tremor Behavioral: Ataxia | JJATDK 3,161,1983 |
| intravenous/woman | lowest published toxic dose: 48 µg/kg | Behavioral: Headache Vascular: BP lowering not characterized in autonomic section Reproductive: Maternal effects: Uterus, cervix, vagina | FCLPH* 18,207,2004 |
| intravenous/woman | lowest published toxic dose: 3.77 µg/kg/60M | Behavioral: Headache Cardiac: Pulse rate decreased with fall in BP Vascular: BP lowering not characterized in autonomic section | CEXPB9 35,580,2008 |
| oral/guinea pig | lethal dose (50 percent kill): 1450 mg/kg | Cardiac: Other changes Lung, Thorax, or Respiration: Cyanosis Blood: Methemoglobinemia- Carboxhemoglobinemia | STGNBT -,180,1999 |
| oral/human | lowest published toxic dose: 0.0083 mg/kg | Cardiac: Change in rate Vascular: Measurement of regional blood flow | FATOAO 49,84,1986 |
| oral/human | lowest published toxic dose: 0.004 mg/kg | Cardiac: Change in rate Cardiac: Cardiac output Vascular: Other changes | BCLPT* 102(Suppl 1),50,2008 |
| oral/human | lowest published toxic dose: 0.004 mg/kg | Vascular: Other changes | BCLPT* 102(Suppl 1),50,2008 |
| oral/mammal (species unspecified) | lethal dose (50 percent kill): 105 mg/kg | TOVEFN (1),14,2001 | |
| oral/mouse | lethal dose (50 percent kill): 1055 mg/kg | Behavioral: Ataxia Lung, Thorax, or Respiration: Respiratory depression | HPV319 -,-,2002 |
| oral/mouse | lethal dose (50 percent kill): 115 mg/kg | Behavioral: Somnolence (general depressed activity) | YACHDS 13,3649,1985 |
| oral/rabbit | lethal dose (50 percent kill): 1607 mg/kg | NIIRDN -,786,1990 | |
| oral/rat | lethal dose (50 percent kill): 105 mg/kg | Behavioral: Somnolence (general depressed activity) | YACHDS 13,3649,1985 |
| oral/rat | lowest published toxic dose: 1360 mg/kg | Brain and Coverings: Other degenerative changes Behavioral: Tetany Cardiac: Cardiomyopathy including infarction | FATOAO 48,76,1985 |
| oral/rat | lowest published toxic dose: 10 mg/kg | Vascular: Measurement of regional blood flow Gastrointestinal: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases | JPHPH* 59,103,2008 |
| oral/rat | lowest published toxic dose: 10 mg/kg | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other oxidoreductases Biochemical: Metabolism (intermediary): Lipids including transport | JPHPH* 59,103,2008 |
| oral/rat | lethal dose (50 percent kill): 685 mg/kg | Gastrointestinal: Other changes | HPV319 -,-,2002 |
| oral/woman | lowest published toxic dose: 5 mg/kg | Behavioral: General anesthetic Cardiac: Other changes Kidney, Ureter, and Bladder: Incontinence | NAYXEW 8,181,1988 |
| oral/woman | lowest published toxic dose: 8 µg/kg | Behavioral: Headache Cardiac: Pulse rate decreased with fall in BP Gastrointestinal: Nausea or vomiting | AJEMEN 11,253,1993 |
| oral/woman | lowest published toxic dose: 8 µg/kg | Cardiac: Pulse rate decreased with fall in BP Vascular: BP lowering not characterized in autonomic section Lung, Thorax, or Respiration: Other changes | AEMED3 23,31,1994 |
| skin/mouse | lethal dose (50 percent kill): >35200 µg/kg | NIIRDN -,786,1990 | |
| skin/rabbit | lethal dose (50 percent kill): >280 mg/kg | NIIRDN -,786,1990 | |
| skin/rat | lethal dose (50 percent kill): >29200 µg/kg | NIIRDN -,786,1990 | |
| subcutaneous/cat | lowest published lethal dose: 150 mg/kg | Liver: Other changes Kidney, Ureter, and Bladder: Other changes in urine composition Blood: Normocytic anemia | AEPPAE 200,271,1942 |
| subcutaneous/mouse | lethal dose (50 percent kill): 110 mg/kg | Behavioral: Somnolence (general depressed activity) | YACHDS 13,3649,1985 |
| subcutaneous/mouse | lowest published toxic dose: 6359 µg/kg | Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | EJPHAZ 501,209,2004 |
| subcutaneous/rabbit | lowest published lethal dose: 400 mg/kg | AEPPAE 200,271,1942 | |
| subcutaneous/rat | lethal dose (50 percent kill): 94 mg/kg | Behavioral: Somnolence (general depressed activity) | YACHDS 13,3649,1985 |
| subcutaneous/rat | lowest published toxic dose: 10 mg/kg | Biochemical: Neurotransmitters or modulators (putative): Catecholamine levels in CNS | PYTOEY 18,788,2011 |
| unreported route/mammal (species unspecified) | lethal dose (50 percent kill): 230 mg/kg | FRXXBL #2454807 | |
| unreported route/rat | lowest published toxic dose: 9504 µg/kg | Vascular: BP lowering not characterized in autonomic section | NSAPCC 375(Suppl 1),64,2007 |
Other Multiple Dose Data and References
| Route/Organism | Dose | Effect | Reference |
|---|---|---|---|
| implant/mouse | lowest published toxic dose: 54506.4 ng/kg/4D- continuous | Cardiac: Other changes Vascular: Relaxation (isolated tissue) Biochemical: Metabolism (intermediary): Effect on mitochondrial function | NSAPCC 375(Suppl 1),107,2007 |
| implant/rat | lowest published toxic dose: 64 mg/kg/48H-continuous | Vascular: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other esterases | JPETAB 317,188,2006 |
| inhalation/mammal (species unspecified) | lowest published toxic concentration: 86 µg/m3/17W- intermittent | Brain and Coverings: Other degenerative changes Liver: Fatty liver degeneration Cardiac: EKG changes not diagnostic of above | STGNBT -,180,1999 |
| intraperitoneal/rat | lowest published toxic dose: 825 mg/kg/33D- continuous | Kidney, Ureter, and Bladder: Other changes in urine composition Nutritional and Gross Metabolic: Weight loss or decreased weight gain Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Phosphatases | YACHDS 13,3689,1985 |
| intraperitoneal/rat | lowest published toxic dose: 1575 mg/kg/13W- intermittent | Endocrine: Changes in adrenal weight Nutritional and Gross Metabolic: Changes in: K Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | YACHDS 13,3753,1985 |
| intraperitoneal/rat | : 15 mg/kg/15D- intermittent | Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Catalases Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | EJPHAZ 541,191,2006 |
| intravenous/Dog | lowest published toxic dose: 300 mg/kg/30D- intermittent | Lung, Thorax, or Respiration: Respiratory stimulation Endocrine: Changes in thymus weight Blood: Changes in platelet count | YACHDS 13,3753,1985 |
| multiple/rat | lowest published toxic dose: 64.3 mg/kg/48H- intermittent | Vascular: BP lowering not characterized in autonomic section Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other enzymes | JPETAB 317,188,2006 |
| oral/Dog | lowest published toxic dose: 365 mg/kg/1Y- continuous | Blood: Methemoglobinemia- Carboxhemoglobinemia Blood: Changes in erythrocyte (RBC) count | HPV319 -,,2002 |
| oral/human | lowest published toxic dose: 0.6 mg/kg/14D- intermittent | Cardiac: Change in force of contraction Cardiac: Change in rate Vascular: Measurement of regional blood flow | FATOAO 49,84,1986 |
| oral/mouse | lowest published toxic dose: 70372 mg/kg/2Y- continuous | Behavioral: Food intake (animal) Blood: Methemoglobinemia- Carboxhemoglobinemia Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | HPV319 -,,2002 |
| oral/rabbit | lowest published toxic dose: 30 mg/kg/26W- continuous | Cardiac: Cardiomyopathy including infarction Cardiac: EKG changes not diagnostic of above Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | FATOAO 48,76,1985 |
| oral/rabbit | lowest published toxic dose: 4080 mg/kg/30D- intermittent | Cardiac: EKG changes not diagnostic of above Cardiac: Pulse rate increased without fall in BP | FATOAO 48,76,1985 |
| oral/rat | lowest published toxic dose: 22995 mg/kg/2Y- continuous | Blood: Other changes Blood: Changes in erythrocyte (RBC) count | HPV319 -,,2002 |
| oral/rat | lowest published toxic dose: 22.75 mg/kg/26W- continuous | Cardiac: Cardiomyopathy including infarction Cardiac: EKG changes not diagnostic of above Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | FATOAO 48,76,1985 |
| oral/rat | lowest published toxic dose: 4080 mg/kg/30D- intermittent | Cardiac: EKG changes not diagnostic of above Cardiac: Pulse rate increased without fall in BP Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects | FATOAO 48,76,1985 |
| skin/rabbit | lowest published toxic dose: 4900 mg/kg/5W- intermittent | Endocrine: Changes in thymus weight Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Blood: Changes in leukocyte (WBC) count | KSRNAM 18,2794,1984 |
| skin/rat | lowest published toxic dose: 1500 mg/kg/30D- intermittent | Blood: Pigmented or nucleated red blood cells Blood: Changes in serum composition (e.g. TP, bilirubin, cholesterol) Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Transaminases | YACHDS 9,1477,1981 |
| skin/rat | lowest published toxic dose: 25480 mg/kg/26W- intermittent | Liver: Other changes Blood: Pigmented or nucleated red blood cells Blood: Changes in platelet count | KSRNAM 18,2817,1984 |
| skin/woman | lowest published toxic dose: 32 mg/kg/20D- intermittent | Skin: After topical application: Dermatitis, allergic | CODEDG 45,299,2001 |
| unreported route/rat | lowest published toxic dose: 28512 µg/kg/3D- continuous | Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases | NSAPCC 375(Suppl 1),64,2007 |
Reviews
| Organization | Standard | Reference |
|---|---|---|
| American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.05 ppm (skin) | DTLVS* TLV/BEI,2013 |
| TOXICOLOGY REVIEW | NTIS** AD778-725 | |
| TOXICOLOGY REVIEW | ARPTDI 43,97,2003 | |
| TOXICOLOGY REVIEW | MUREAV 488,151,2001 | |
| TOXICOLOGY REVIEW | TPHSDY 23,401,2002 | |
| TOXICOLOGY REVIEW | EMMUEG 43,143,2004 | |
| TOXICOLOGY REVIEW | MUREAV 612,115,2006 | |
| TOXICOLOGY REVIEW | BJPCBM 146,479,2005 | |
| TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
| TOXICOLOGY REVIEW | TOPADD 33,517,2005 | |
| TOXICOLOGY REVIEW | HUTOX* -,395,1996 | |
| TOXICOLOGY REVIEW | DERCL* 27,289,2009 | |
| TOXICOLOGY REVIEW | NCLNA* 16,107,1998 | |
| TOXICOLOGY REVIEW | NCLNA* 16,107,1998 | |
| TOXICOLOGY REVIEW | MUREAV 750,1,2012 |
Standards and Regulations
| Organization | Standard | Reference |
|---|---|---|
| Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
| Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
| Occupational Exposure Limit-ARAB Republic of Egypt | time-weighted average 0.02 ppm (0.2 mg/m3), Skin, JAN1993 | |
| Occupational Exposure Limit-AUSTRALIA | time-weighted average 0.05 ppm (0.46 mg/m3), JUL2008 | |
| Occupational Exposure Limit-AUSTRIA | MAK-TMW 0.05 ppm (0.5 mg/m3);KZW 0.2 ppm (2 mg/m3), skin, 2007 | |
| Occupational Exposure Limit-BELGIUM | time-weighted average 0.05 ppm (0.47 mg/m3), Skin, MAR2002 | |
| Occupational Exposure Limit-DENMARK | ceiling concentration 0.02 ppm (0.2 mg/m3), skin, MAY2011 | |
| Occupational Exposure Limit-FINLAND | time-weighted average 0.03 ppm (0.3 mg/m3), short term exposure limit 0.1 ppm (1 mg/m3), skin, NOV2011 | |
| Occupational Exposure Limit-FRANCE | VME 0.1 ppm (1 mg/m3), Skin, FEB2006 | |
| Occupational Exposure Limit-GERMANY | MAK 0.01 ppm (94 µg/m3), 2011 | |
| Occupational Exposure Limit-HUNGARY | time-weighted average 0.5 mg/m3, short term exposure limit 2 mg/m3, Skin, SEP2000 | |
| Occupational Exposure Limit-ICELAND | short term exposure limit 0.02 ppm (0.2 mg/m3), skin, NOV2011 | |
| Occupational Exposure Limit-JAPAN | ceiling concentration 0.05 ppm (0.46 mg/m3), skin, MAY2012 | |
| Occupational Exposure Limit-KOREA | time-weighted average 0.05 ppm (0.5 mg/m3), skin, 2006 | |
| Occupational Exposure Limit-MEXICO | time-weighted average 0.05 ppm (0.5 mg/m3);short term exposure limit 0.1 ppm (1 mg/m3), 2004 | |
| Occupational Exposure Limit-NEW ZEALAND | time-weighted average 0.05 ppm (0.46 mg/m3), skin, JAN2002 | |
| Occupational Exposure Limit-NORWAY | time-weighted average 0.03 ppm (0.27 mg/m3), JAN1999 | |
| Occupational Exposure Limit-PERU | time-weighted average 0,05 ppm (0,46 mg/m3), JUL2005 | |
| Occupational Exposure Limit-POLAND | MAC(time-weighted average) 0.5 mg/m3, MAC(short term exposure limit) 1 mg/m3, JAN1999 | |
| Occupational Exposure Limit-RUSSIA | short term exposure limit 0.02 mg/m3, Skin, JUN2003 | |
| Occupational Exposure Limit-SWEDEN | time-weighted average 0.03 ppm (0.3 mg/m3);short term exposure limit 0.1 ppm (0.9 mg/m3), Skin, JUN2005 | |
| Occupational Exposure Limit-SWITZERLAND | ceiling concentration 0.01 ppm (0.094 mg/m3), skin, JAN2011 | |
| Occupational Exposure Limit-THAILAND | time-weighted average 0.2 ppm (2 mg/m3), JAN1993 | |
| Occupational Exposure Limit-THE NETHERLANDS | MAC-TGG 0.5 mg/m3, Skin, 2003 | |
| Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 0.2 ppm (2 mg/m3), Skin, JAN1993 | |
| Occupational Exposure Limit-TURKEY | time-weighted average 0.2 ppm (2 mg/m3), Skin, JAN1993 | |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | ceiling concentration 0.2 ppm (2 mg/m3) (skin) | CFRGBR 29,1926.55,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | ceiling concentration 0.2 ppm (2 mg/m3) (skin) | CFRGBR 41,50-204.50,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | ceiling concentration 0.2 ppm (2 mg/m3) (skin) | CFRGBR 29,1910.1000,1994 |
| Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | ceiling concentration 0.2 ppm (2 mg/m3) (skin) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
| Organization | Standard | Reference |
|---|---|---|
| National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO NITROGLYCERIN-air | short term exposure limit 0.1 mg/m3 (Sk) | NIOSH* DHHS #92-100,1992 |
| National Occupational Exposure Survey 1983 | Hazard Code 50890; Number of Industries 3; Total Number of Facilities 384; Number of Occupations 9; Total Number of Employees Exposed 38471; Total Number of Female Employees Exposed 29144 | |
| National Occupational Hazard Survey 1974 | Hazard Code 50890; Number of Industries 4; Total Number of Facilities 413; Number of Occupations 10; Total Number of Employees Exposed 4331 |
Status in Federal Agencies
| Organization | Reference |
|---|---|
| EPA TSCA Section 8(b) CHEMICAL INVENTORY | |
| EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 | |
| NIOSH Analytical Method, 1994: Nitroglycerin, 2507 | |
| OSHA ANALYTICAL METHOD #43 |
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division